CRIS Current Research Information System

GANDOLFI, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.661
EU - Europa 1.018
AS - Asia 446
AF - Africa 74
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.650
GB - Regno Unito 291
SE - Svezia 241
VN - Vietnam 204
CN - Cina 162
DE - Germania 135
IT - Italia 95
IN - India 51
FR - Francia 46
IE - Irlanda 45
UA - Ucraina 37
RU - Federazione Russa 36
TG - Togo 31
ZA - Sudafrica 26
EE - Estonia 25
CA - Canada 11
FI - Finlandia 11
BE - Belgio 10
CH - Svizzera 10
HR - Croazia 9
NG - Nigeria 9
BG - Bulgaria 7
IR - Iran 7
LB - Libano 7
PL - Polonia 7
CI - Costa d'Avorio 6
BR - Brasile 5
JO - Giordania 4
JP - Giappone 4
ES - Italia 3
HK - Hong Kong 2
NL - Olanda 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 3.205
Salva come PNG Salva come JPEG
Città #
Southend 257
Fairfield 246
Ashburn 162
Chandler 151
Houston 132
Woodbridge 129
Seattle 111
Ann Arbor 105
Wilmington 97
Cambridge 87
Dong Ket 67
Princeton 62
Dublin 45
Lomé 31
Nanjing 30
Westminster 27
Padova 26
Berlin 24
New York 23
Jinan 22
Bremen 21
Boardman 16
Jacksonville 16
Dearborn 13
Beijing 12
Bologna 12
San Diego 12
Shenyang 12
Changsha 11
Hebei 11
Helsinki 11
Brussels 10
Hangzhou 10
Nanchang 10
Toronto 10
Bern 9
Abeokuta 8
Jiaxing 7
Turin 7
Abidjan 6
Falls Church 6
Florence 6
Los Angeles 6
Saint Petersburg 6
Falconara Marittima 5
Haikou 5
Monmouth Junction 5
Norwalk 5
Paris 5
Redwood City 5
Sofia 5
Taizhou 5
Tianjin 5
Warsaw 5
Amman 4
Lanzhou 4
Taiyuan 4
Zhengzhou 4
Andover 3
Bühl 3
Guangzhou 3
London 3
Milan 3
Mülheim 3
Olalla 3
Redmond 3
Rijeka 3
San Francisco 3
São Paulo 3
Tokyo 3
Wayne 3
Ardabil 2
Dallas 2
Des Moines 2
Fremont 2
Greenock 2
Groningen 2
Henderson 2
Leawood 2
Mahé 2
Ningbo 2
Pramaggiore 2
Reggio Emilia 2
Verona 2
Zanjan 2
Alcalá De Henares 1
Bonemerse 1
Brandenburg 1
Bratislava 1
Brescia 1
Castelliri 1
Chandigarh 1
Chennai 1
Chicago 1
Clearwater 1
Council Bluffs 1
Frankfurt am Main 1
Gallarate 1
Gallo 1
Hefei 1
Totale 2.230
Salva come PNG Salva come JPEG
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 188
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. 187
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 172
Is it really possible to cure hairy cell leukemia patients only with frontline therapy? 145
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. 145
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study 142
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. 141
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience 137
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study 130
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 129
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients. 126
Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis 118
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma). 111
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. 110
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature 108
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients 105
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. 103
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. 103
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma. Leuk Lymphoma. 98
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. 98
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients 95
Vemurafenib mucosal side-effect. 94
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results 89
Primary ocular adnexal lymphomas: a retrospective study of 25 patients. 87
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 84
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients. 83
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma. 71
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 45
A possible source of Campylobacter pylori? ELISA testing of abattoir workers 8
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 6
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 5
CAMPYLOBACTER PYLORI IN ABATTOIR WORKERS: IS IT A ZOONOSIS? 5
CAMPYLOBACTER PYLORI IN ABATTOIR WORKERS: IS IT A ZOONOSIS? 4
Cancer of the gastric stump in Italy, 1979–1986 3
Endoscopic retrograde cholangiopancreatography (ERCP) in the elderly 3
Cancer of the gastric stump in Italy, 1979–1986 2
The source of Campylobacter pylori 1
IS CAMPYLOBACTER PYLORI A ZOONOSIS? 1
The source of Campylobacter pylori 1
Totale 3.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.294
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201977 0 0 0 0 0 0 0 0 0 28 19 30
2019/2020990 119 26 5 55 112 122 123 126 142 71 45 44
2020/2021509 87 29 23 16 14 26 3 24 50 24 24 189
2021/2022648 103 36 34 67 52 28 19 32 20 31 118 108
2022/2023687 83 110 51 93 43 65 13 45 78 20 38 48
2023/2024196 30 28 13 34 15 31 26 3 4 12 0 0
Totale 3.283